Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 393,700 shares, an increase of 666.0% from the July 31st total of 51,400 shares. Currently, 12.5% of the shares of the company are sold short. Based on an average daily volume of 544,900 shares, the short-interest ratio is presently 0.7 days.
Entero Therapeutics Price Performance
Entero Therapeutics stock traded up $0.00 during trading on Tuesday, hitting $0.44. The stock had a trading volume of 110,351 shares, compared to its average volume of 339,179. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.40. The company’s 50 day moving average price is $0.91. Entero Therapeutics has a 1 year low of $0.19 and a 1 year high of $22.20.
Entero Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Entero Therapeutics
- Bank Stocks – Best Bank Stocks to Invest In
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- With Risk Tolerance, One Size Does Not Fit All
- Brinker International Offers a Pullback Opportunity on EPS Miss
- Using the MarketBeat Dividend Yield Calculator
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.